Navigation Links
Goa to Host International Vegetarian Congress

India will host the 37th edition of the International Vegetarian Congress in Goa from Sep 10.The six-day congress, organised by International Vegetarian Union//, will discuss the challenges vegetarians face across the globe. Jashu C. Shah, president of the Asian Vegetarian Union, said in a statement that the congress would help participants understand India as a country where vegetarianism is a way of life.

The conference would also discuss issues like ecology, genetic engineering, environment, spiritualism and alternate therapies, Shah said.



Source-IANS
'"/>




Page: 1

Related medicine news :

1. International community warns India on HIV situation
2. Key step forward on International Health Rules
3. ICMR along with other International Research organisation with drug development for Neglected Diseases
4. International Osteoporosis Research Centre To Be Started In India.
5. Indian hospitals require International Accreditation
6. International Conference On Malaria - Laveran To Genomics
7. Delhi To Host International Women’s Congress From Nov 2
8. International conference on Ayurveda to be held on Kerala
9. International Teleradiology: The Future Of Radiologic Diagnosis
10. John Mendelsohn M.D, chosen for an International Award
11. Thailand To Procure Botulism Antitoxin Internationally
Post Your Comments:
(Date:10/10/2008)... Upon the completion of a highly succes...CDM Media proudly announces their next business te...ation technology executives in healthcare. CDM Med...unch May 10-12, 2009 at the Four Seasons Resort in...lu, HI (PRWEB) October 11, 2008 -- Upon the comple...
(Date:10/10/2008)... Utah, Oct. 10 /PRNewswire/ -- NuView Life Science... Trace Life Sciences Inc.,(Trace), including opera...uction facilities in Denton, Texas. The Trace faci...odine-123 and Thallium-201 used in,molecular imagi...an and,CEO, stated that "We are confident that by ...
(Date:10/10/2008)...APISTRANO, Calif., Oct. 10 /PRNewswire/ -- A senio...h,s Uinta Mountains in a small,plane. The high-fly...t Roy,Heden. The thrill came from a last-wish prog...ilverado Senior Living, where Heden was a patient.... cards and it has helped,many realize a special ac...
(Date:10/10/2008)...y Warlick Teams Up with Legal and Medical Panel to...r and Careers Seminar in,Knoxville, KNOXVILLE, Te...ional,Breast Cancer Awareness Month, Cancer and Ca...orces with YWCA Knoxville, The Wellness Community-...rlick, University of Tennessee,women,s basketball ...
Breaking Medicine News(10 mins):Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4
... bird flu pandemic still looms large, a new study ... workers and other people who are exposed to pigs ...nza.// The study, which is published in the Jan. 1...ous Diseases, describes that the physical makeup o...
...to 800 women from 55 countries who will be the fou...27. // The four-day international congress titled ...or the first time in South Asia. The earlier meeti...996), Rio de Janeiro (1999) and Stockholm (2002). ...
...ree more cases of bird flu, even as the government...vaccine against the virus.// The latest outbreaks ...ar-western region of Xinjiang, the southwestern pr...hwestern region of Ningxia, the agriculture minist...
...ed with the aim to combat AIDS will exploit the un... computers around the world to aid research and id...ency Virus (HIV).// The Internet-based initiativ...list about 100,000 computer users to donate the us...
Other Medicine News:Health News:Delhi To Host International Women’s Congress From Nov 2 2
(Date:10/9/2008)...ted in November 2008, BOTHELL, Wash., Oct. 9 /PRN...DD ) announced today the completion of patient enr...tal trials to evaluate the safety and,efficacy of ...buprofen for,the over-the-counter (OTC) market. Th...this pivotal trial in November 2008. Ibuprofen is ...
(Date:10/8/2008)...wire-USNewswire/ -- The facts are,overwhelming. Ev...sub-Saharan Africa. More than 35,000,000 women, ch... died of AIDS. The Foundation for Hospices,in Sub-...their families,find compassion and relief from suf...nering initiative links African hospices and palli...
(Date:10/8/2008)...s Research That May Offer New Hope to,Heart Failur...nally, over 3,000 people are,waiting for a heart t...alf,of those will receive a transplant. Now, pione... paving the way for how to treat congestive heart,...ews Release, go to:, http://www.prnewswire.com/mnr...
(Date:10/8/2008)...e TAXUS(R) Element(TM) Platinum Chromium ... 8 /- Boston Scientific,Cor... completed enrollment in,the PERSEUS trial, design...S(R) Element(TM) paclitaxel-eluting coronary stent... 1,500 patients at 100 U.S. and,international cent...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 1Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 2Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 3Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 4Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 5Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 6Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 7Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 8Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 9Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 10Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 11Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 12Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 13Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 14Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 15Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 16Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 17Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 18Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 19Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 20Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 21Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 22Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 23Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 24Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 25Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 26Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 27Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 28Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 29Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 30Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 31Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 32Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 33Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 34Sanofi aventis Announces a Good Third Quarter Performance 3B Increase in 2007 full year earnings growth guidance 5103 35Varian Inc Offers New Products for the Rapid Purification of Synthetic Oligonucleotides 5098 1Varian Inc Offers New Products for the Rapid Purification of Synthetic Oligonucleotides 5098 2Childrens gardens mushrooming 1053 1Childrens gardens mushrooming 1053 2Caesarean births pose higher risks for mother and baby 5096 1Caesarean births pose higher risks for mother and baby 5096 2
... July 3, 2007-- – The appearance of a,rash i... is,strongly associated with longer survival, acco...er, OSI Pharmaceuticals, Inc. This is,not the firs...al,advantage with EGFR inhibitors – a class ...tumumab and others designed to,block overproductio...
... July 3, 2007-- Ongoing therapeutic cancer vaccine...ring a,patient’s immune system to shrink tum...trials tend to live longer and respond,better to s...al,Cancer Research, a journal of the American Asso...ncer Institute researchers asks a,fundamental ques...
Other Medicine Technology:Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 2Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 3Skin Rash Actually Signifies Better Outcomes for Pancreatic and,Lung Cancer Patients 4From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 2From Clinical Cancer Research: Rethinking Therapeutic Cancer,Vaccine Trials 3
Triad Plus Skin Protectant Swabsticks prepare the skin for maximum adhesion of a dressing or bandage. When dry, they leave a thin film on the skin's surface. This provides a clean surface and a barri
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness.
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick.
BD Persist contains 70% alcohol and 10% povidone iodine formulated in a unique polymer base, forming a barrier on the skin. The barrier creates a protective environment for the povidone iodin
Medicine Products: